MSD Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare

Strategic Transaction Benefits and Improves Aquaculture Health and Performance

MADISON, N.J., Dec. 17, 2019 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of Vaki, a leader in fish farming and wild fish conservation monitoring equipment and real-time video monitoring technology to advance fish health and welfare, from Pentair (NYSE:PNR), a leading global water treatment company.

Today’s announcement further positions MSD Animal Health as a global leader in broadening its aquaculture portfolio by expanding into complementary fish farming and conservation areas to generate outcomes with precision farming and fish welfare solutions, which complement its existing portfolio of vaccines and pharmaceuticals. Vaki will be a leading brand under the Biomark business within MSD Animal Health, focused on a range of equipment, products and technology for fish counting and size estimation from freshwater to saltwater rearing, while collecting data and analytics for each stage of fish production.

“Animal health intelligence and enhanced technology play an increasingly important role in animal health and care, providing access to real-time actionable data and insights to help, improve or enhance animal management and health outcomes,” said Rick DeLuca, president, MSD Animal Health. “We continue to execute upon our strategy to expand and add breadth to our portfolio and its technology. We are at the technological forefront of shaping the future of animal health through our commitment to leveraging our scientific capabilities and expertise through comprehensive solutions to manage the health and well-being of animals. We are excited to take this step forward with Vaki, as we add leading technology and services, which extend the range of solutions in aquaculture we can provide to our customers.”

Karl Frykman, executive vice president and chief operating officer at Pentair, said, “We are proud of Vaki’s transformation over the past years. Vaki has significant potential to continue to spearhead development in the aquaculture industry and we believe that MSD Animal Health is an ideal partner to support the next stage of its growth.”

Biomark specializes in electronic identification technology used in fisheries, wildlife and aquaculture research, including product sales, custom manufacturing, installation and extensive data management and analysis.

In April 2019, MSD Animal Health announced the completion of its acquisition of Antelliq Corporation and its brands, Allflex Livestock Intelligence, Sure Petcare and Biomark, as leaders in emerging digital technology with animal identification, animal monitoring and smart data management for Livestock and Companion Animals. In March 2019, MSD Animal Health  acquired Scan Aqua AS, a fish health and fish welfare company based in Norway, focused on key aquaculture products.

About MSD Animal Health

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit or connect with us on LinkedIn and Twitter.

About Pentair plc

At Pentair, we believe the health of our world depends on reliable access to clean, safe water. We deliver a comprehensive range of smart, sustainable water solutions to homes, business and industry around the world. Our industry leading and proven portfolio of solutions enables our customers to access clean, safe water. Whether it’s improving, moving or enjoying water, we help manage the world’s most precious resource. Smart, Sustainable, Water Solutions. For Life.

Pentair had revenue in 2018 of $3 billion, and trades under the ticker symbol PNR. With approximately 110 locations in 30 countries and 10,000 employees, we believe that the future of water depends on us. To learn more, visit